Abstract:
Objective To investigate the expression of IQGAP1 in breast cancer tissues and their tumor-adjacent normal tissues and the effect of IQGAP1 on the proliferation of breast cancer cells.
Methods A total of 110 breast invasive ductal cancer (IDC) and its adjacent normal tissues specimens were screened for the expression of IQGAP1 with streptavidin-perosidase (S-P) immunohistochemistry. IQGAP1 gene expression was regulated in MCF-7 and MCF-10A cell line.
Results The expression of IQGAP1 was higher in breast cancer tissues than in tumor-adjacent normal tissues (P = 4.23×10-6). The expression of IQGAP1 was correlated with tumor size, and was significantly higher in tumor > 2 cm than in tumor ≤ 2 cm (P = 0.006), but was not correlated with lymphnode metastasis (P = 0.870), clinical staging (P = 0.278), expression of estrogen receptor (ER) (P = 0.412) or progestogen receptor (PR) (P = 0.248) in IDC. IQGAP1 high expression was associated with poor progression free time (P = 0.008) and overall survival time (P = 0.029) among breast cancer patients. The proliferation rate of MCF-7 cells was significantly decreased after knocking down IQGAP1 expression.
Conclusion IQGAP1 may play important roles in the development of breast cancer.